Benefits sought for men with andrological problems

NEWS BRIEFS

Benefits sought for men with andrological problems

/ 05:34 AM November 13, 2024

Benefits sought for men with andrological problems

Inquirer stock photo

MANILA, Philippines — A bill filed in the House of Representatives has proposed a paid two-week leave of absence and other benefits for men who undergo procedures for reproductive system-related conditions such as prostate cancer, infertility and other ailments.

Batangas Rep. Gerville Luistro’s House Bill No. 11020, or the Special Workplace Benefits for Men Act of 2024, seeks to bring attention to the “often-overlooked” issue of andrological procedures and promote accessible treatment options for conditions unique to men.

Article continues after this advertisement

“A male member of the workforce having rendered continuous aggregate employment service of at least six months for the last 12 months shall be entitled to a special leave benefit of two weeks with full pay based on his gross monthly compensation following surgery caused by andrological disorders,” it stated.

FEATURED STORIES

The bill also wants a “Male Andrological Section” in all public hospitals, medical centers and institutions to provide health services to male workers.

HB 11020 further ensures that men have access to comprehensive and gender-responsive health services and programs as well as complete, timely and accurate information about their health.

Article continues after this advertisement

It tasks the Department of Health and Department of Social Welfare and Development to implement and craft the guidelines for the measure. —Jeannette I. Andrade

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

business
business
globalnation
globalnation
www
TAGS: House bill, male, paid leaves

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.